A cost comparison of two strategies for treating stage IB2 cervical cancer

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 274-278

  Lachance, J A ^a   Darus, C J ^a   Stukenborg, G J ^a   Schneider, B F ^a   Rice, L W ^a   Jazaeri, A A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adjuvant hysterectomy; Cervical cancer; Chemoradiation; Cost minimization

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COST MINIMIZATION ANALYSIS; DEMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYSTERECTOMY; OPERATING ROOM; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; RADIOTHERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 40549101073     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01007.x     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 : 57 : 43 66.
2. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003 9 : 348 59.
3. Holtz DO, Dunton C. Traditional management of invasive cervical cancer. Obstet Gynecol Clin North Am 2002 29 : 645 57.
4. Azria E, Morice P, Haie-Meder C et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 2005 12 : 332 7.
5. Gallion HH, van NJ Jr., Donaldson ES et al. Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 1985 56 : 262 5.
6. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999 340 : 1154 61.
7. Keys HM, Bundy BN, Stehman FB et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003 89 : 343 53.
8. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery vs radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997 350 : 535 40.
9. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WE, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial? Int J Radiat Oncol Biol Phys 1991 21 : 899 904.
10. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy vs no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999 73 : 177 83.
11. Darus CJ, Callahan MB, Nguyen Q et al. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma. Gynecol Oncol 2006 101 : S158.
12. Einbinder JS, Scully K. Using a clinical data repository to estimate the frequency and costs of adverse drug events. Proc AMIA Symp 2001 154 8.
13. Einbinder JS, Scully KW, Pates RD, Schubart JR, Reynolds RE. Case study: a data warehouse for an academic medical center. J Healthc Inf Manag 2001 15 : 165 75.
14. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001 22 : 91 113.
15. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002 40 (Suppl. 8 IV 104 17.
16. El MT, Arveux P, Gay C et al. Estimation of the treatment cost of cervical cancer. Rev Epidemiol Sante Publique 1997 45 : 508 15.
17. Wolstenholme JL, Whynes DK. Stage-specific treatment costs for cervical cancer in the United Kingdom. Eur J Cancer 1998 34 : 1889 93.
18. Rocconi RP, Estes JM, Leath CA III., Kilgore LC, Huh WK, Straughn JM Jr. Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis. Gynecol Oncol 2005 97 : 387 94.
19. Falkenberg E, Kim RY, Meleth S, De Los SJ, Spencer S, Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: the University of Alabama at Birmingham (UAB) experience. Brachytherapy 2006 5 : 49 55.
20. Ferrigno R, Nishimoto IN, Novaes PE et al. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Int J Radiat Oncol Biol Phys 2005 62 : 1108 16.
21. Petereit DG, Sarkaria JN, Potter DM, Schink JC. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence - the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 1999 45 : 1267 74.
22. Stewart AJ, Viswanathan AN. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer 2006 107 : 908 15.
23. Sardi JE, Giaroli A, Sananes C et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997 67 : 61 9.